ArticlePDF Available

Effects of dietary coconut oil, butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels


Abstract and Figures

The aim of this present study was to determine plasma levels of lathosterol, lipids, lipoproteins and apolipoproteins during diets rich in butter, coconut fat and safflower oil. The study consisted of sequential six week periods of diets rich in butter, coconut fat then safflower oil and measurements were made at baseline and at week 4 in each diet period. Forty-one healthy Pacific island polynesians living in New Zealand participated in the trial. Subjects were supplied with some foods rich in the test fats and were given detailed dietary advice which was reinforced regularly. Plasma lathosterol concentration (P < 0.001), the ratio plasma lathosterol/cholesterol (P=0.04), low density lipoprotein (LDL) cholesterol (P<0.001) and apoB (P<0.001) levels were significantly different among the diets and were significantly lower during coconut and safflower oil diets compared with butter diets. Plasma total cholesterol, HDL cholesterol and apoA-levels were also significantly (P< or =0.001) different among the diets and were not significantly different between buffer and coconut diets. These data suggest that cholesterol synthesis is lower during diets rich in coconut fat and safflower oil compared with diets rich in butter and might be associated with lower production rates of apoB-containing lipoproteins.
Content may be subject to copyright.
Effects of dietary coconut oil, butter and safflower oil on plasma
lipids, lipoproteins and lathosterol levels
C Cox
, W Sutherland
, J Mann
, S de Jong
, A Chisholm
and M Skeaff
Departments of
Human Nutrition and
Medicine, University of Otago, Dunedin, New Zealand
Objective: The aim of this present study was to determine plasma levels of lathosterol, lipids, lipoproteins and
apolipoproteins during diets rich in butter, coconut fat and saf¯ower oil.
Design: The study consisted of sequential six week periods of diets rich in butter, coconut fat then saf¯ower oil
and measurements were made at baseline and at week 4 in each diet period.
Subjects: Forty-one healthy Paci®c island polynesians living in New Zealand participated in the trial.
Interventions: Subjects were supplied with some foods rich in the test fats and were given detailed dietary
advice which was reinforced regularly.
Results: Plasma lathosterol concentration (P < 0.001), the ratio plasma lathosterol/cholesterol (P 0.04), low
density lipoprotein (LDL) cholesterol (P < 0.001) and apoB (P < 0.001) levels were signi®cantly different
among the diets and were signi®cantly lower during coconut and saf¯ower oil diets compared with butter diets.
Plasma total cholesterol, HDL cholesterol and apoA-levels were also signi®cantly (P 0.001) different among
the diets and were not signi®cantly different between buffer and coconut diets.
Conclusions: These data suggest that cholesterol synthesis is lower during diets rich in coconut fat and saf¯ower
oil compared with diets rich in butter and might be associated with lower production rates of apoB-containing
Sponsorship: The study was supported by the Health Research Council of New Zealand and the Anderson
Telford Trust.
Descriptors: diet; fat type; lathosterol; lipoproteins; polynesians
Diets rich in saturated fatty acids (SAFA) raise plasma
cholesterol and low density lipoprotein (LDL) cholesterol
levels compared with diets rich in polyunsaturated fatty
acids (PUFA). Saturated fatty acids with different chain
lengths vary in their hypercholesterolemic effect in the
order of increasing potency myristate, palmitate and laurate
(Denke & Grundy, 1992; Zock et al, 1994; Cox et al,
1995). Differences in plasma LDL cholesterol when these
fatty acids are predominant in the diet are theoretically due
to differences in the rates of very low density lipoprotein
(VLDL) production and conversion to LDL or the catabol-
ism of LDL by hepatic receptors or both. There is limited
evidence that diets rich in palmitic acid stimulate the
production of very low density lipoproteins (VLDL) and
LDL (Cortese et al, 1983). The rate of VLDL secretion
from the liver is closely linked to cholesterol synthesis rates
in normolipidemic subjects (Watts et al, 1995). Whether
cholesterol synthesis varies during diets rich in SAFA of
different chain lengths has not been widely studied.
The effect of changing the quality of dietary fat on
cholesterol synthesis is controversial. While several studies
have indicated that whole-body cholesterol synthesis is
unchanged (Shepherd et al, 1980; Spritz et al, 1965;
Grundy & Ahrens, 1970; Nestel et al, 1976) others have
documented decreased (Glatz & Katan, 1993) and
increased (Jones et al, 1994) rates when PUFA replace
SAFA in the diet. A suggested (Glatz & Katan, 1993)
explanation for these varying ®ndings is that the gas
chromatographic (GC) separation of faecal plant sterols
and endogenous sterols, a vital step in the cholesterol
balance method of measuring cholesterol synthesis, may
not have been achieved in the earlier studies before the
advent of capillary GC. Cholesterol balance estimates
whole body cholesterol synthesis as the difference between
dietary intake and excretion of cholesterol and its metabo-
lites in the faeces in the steady state. In view of the
technical dif®culties and the requirement for steady-state
conditions in the cholesterol balance technique, alternative
methods for measuring cholesterol synthesis have been
Plasma lathosterol levels and the ratio plasma latho-
sterol/cholesterol have been established as excellent indices
of cholesterol synthesis. They correlate closely with human
hepatic 3-hydroxy-3-methylglutaryl Coenzyme A (HMG
CoA) reductase activity, the rate limiting step in cholesterol
biosynthesis (Bjo
rkhem et al, 1987) and with whole-body
cholesterol synthesis rates measured by cholesterol balance
(Kempen et al, 1988). Also, levels of the sterol are
decreased when cholesterol synthesis is reduced during
treatment with drugs that inhibit the HMG CoA reductase
enzyme (Kempen et al, 1988) and are increased under
conditions of increased cholesterol synthesis (Miettinen,
1985). Lathosterol is a cholesterol precursor that is formed
after the rate-limiting step in cholesterol biosynthesis and
`leaks' from cells at rates which are proportional to
rates of cellular cholesterol synthesis. Plasma lipoproteins
are acceptors for precursor sterols released from cells.
Correspondence: Dr W Sutherland, Department of Medicine, Dunedin
School of Medicine, PO Box 913, Dunedin, New Zealand.
Received 4 December 1997; revised 24 April 1998; accepted 9 May 1998
European Journal of Clinical Nutrition (1998) 52, 650±654
ß 1998 Stockton Press. All rights reserved 0954±3007/98 $12.00
Consequently, the ratio plasma lathosterol/cholesterol has
been frequently used to correct for the effect of varying
numbers of lipoprotein acceptors on plasma lathosterol
levels. When PUFA are substituted for SAFA in the diet
plasma latho-sterol levels and the ratio lathosterol/choles-
terol are reduced (Glatz & Katan, 1993) suggesting that
cholesterol synthesis is also reduced.
The aim of the present study was to determine the effect
of diets rich in coconut fat, butter and saf¯ower oil on
plasma levels of lathosterol. The study was conducted in
Paci®c Islanders because these types of diets have parti-
cular relevance in that population. Traditionally, they eat
diets rich in coconut fat but on migration to New Zealand
they increase their intake of other types of fat (Stanhope
et al, 1981).
Subjects and methods
Forty-seven Paci®c Islanders from two Paci®c Island
churches in Dunedin, New Zealand were recruited. Six
subjects dropped out immediately after initial screening and
41 subjects started the dietary phase of the study. The 41
subjects included 24 men and 17 women ages 19±72 y (31
Western Samoans and 10 Cook Islanders) with plasma
cholesterol levels between 4.2 mmol/l and 7.5 mmol/l and
plasma triglycerides less than 3 mmol/l. None was receiv-
ing drugs known to in¯uence lipid metabolism. Character-
istics of the subjects at baseline are shown in Table 1. All
subjects gave informed consent and the study was approved
by the Ethics committee of the Otago Area Health Board.
Study design
The study included a run in period of six weeks followed
by three consecutive six week periods when diets rich in
butter (butter diet), coconut fat (coconut diet) then saf-
¯ower oil (saf¯ower diet) were consumed without washout
periods between the experimental diet periods. A sequen-
tial study design rather than the preferred randomized
crossover design was used to encourage compliance with
the diets because participants frequently ate communally
within the church group. During the run in period partici-
pants completed a food frequency questionnaire to assess
their usual food and nutrient intake and a health question-
naire. Body weight was measured and fasted venous blood
samples were taken on two occasions during the baseline
period and at weeks four and six of each diet period.
Plasma lipids and HDL cholesterol levels were measured in
all blood samples collected. Plasma lathosterol, very low
density lipoprotein (VLDL) cholesterol and apolipopro-
teins A±I, A±II and B were measured on one occasion
during the baseline period and at the four-week point of
each diet period. An earlier study from our laboratories
(Cox et al, 1995) suggested that plasma lipid and lipo-
protein levels had attained equilibrium by four weeks after
a change in the type of fat in the diet.
The experimental diets were designed to provide approxi-
mately 17% protein, 47% carbohydrate and 36% fat as a
fraction of total energy intake. Target values for fat intake
based on an 8.4 MJ/d diet were 84 g total fat for all diets
and including; 39 g fat from butter plus fat from palmitic
acid-rich foods to give an intake of approximately 17 g
palmitic acid (butter diet); 39 g fat from coconut oil to give
an intake of approximately 17 g lauric acid (coconut diet);
and 24 g fat from saf¯ower oil to give an intake of
approximately 17 g linoleic acid (saf¯ower diet). Calcu-
lated intakes of myristic acid and linoleic acid were
approximately similar in the coconut and butter diets. To
encourage dietary compliance, participants were supplied
with butter and cream during the butter diet, coconut
cream, coconut oil and monounsaturated margarine
during the coconut diet and saf¯ower oil and polyunsatu-
rated margarine during the saf¯ower diet. Specially baked
bread including similar amounts of butter, coconut oil or
saf¯ower oil were supplied to the study participants during
the appropriate diet period. Egg yolk was added to the
coconut diet and the saf¯ower diet to maintain approxi-
mately similar cholesterol intake (250±300 mg/d) during
the experimental diets. Subjects assigned to the butter diet
were instructed to eat butter, cream, butter bread, cheese,
meat, ®sh, chicken, fruit and vegetables, rice, noodles, full
cream milk and milk products and were instructed not to
eat coconut cream or products, margarine and cooking oils.
Those assigned to the coconut diet were instructed to eat
coconut cream, coconut bread, monounsaturated margarine,
coconut, ®sh, meat cheese, chicken, fruit and vegetables,
rice, noodles, trim milk and other low fat dairy products
and not to eat butter, cream, other margarines, chicken skin,
deep-fried takeway foods and vegetable oils. Those
assigned to the saf¯ower diet were instructed to eat poly-
unsaturated margarine, saf¯ower oil, saf¯ower bread,
cheese, meat, ®sh, chicken, fruit and vegetables, rice,
noodles, trim milk, low fat dairy products and not to eat
butter, cream, coconut cream and products, cream, reduced
fat cream and deep-fried takeaway foods. Prior to commen-
cing the experimental diets and during each appointment
for blood sampling a dietitian provided detailed dietary
instructions which were reinforced during group sessions
throughout the study. Dietary instruction included ways to
incorporate the test fats in the diet and foods to eat and
foods to avoid during each experimental diet. Menus were
suggested and recipes were provided. Dietary compliance
was assessed from the plasma triglyeride fatty acid com-
position at week 4 of each diet period. All contact with
study participants took place on Sunday mornings in the
church hall after church service.
Table 1 Characteristics of the subjects at baseline
Men Women
Variable n 21 n 16
Age (y) 35 (9) 39 (9)
Body mass index (kg/m
) 29.7 (3.5) 26.8 (5.4)
Fasting blood glucose (mmol/l) 5.12 (0.82) 5.66 (1.56)
Plasma lipids (mmol/l)
Total cholesterol 5.47 (0.89) 5.55 (1.05)
VLDL cholesterol 0.38 (0.27) 0.30 (0.13)
LDL cholesterol 3.50 (0.85) 3.64 (0.95)
HDL cholesterol 1.07 (0.26) 1.13 (0.17)
Triglycerides 1.98 (1.61) 1.50 (0.49)
Plasma apolipoproteins (g/l)
A±I 1.19 (0.19) 1.24 (0.17)
A±II 0.32 (0.09) 0.34 (0.05)
B 0.76 (0.22) 0.78 (0.19)
Lathosterol (mmol/mmol cholesterol) 1.14 (0.41) 1.14 (0.47)
Values are mean (s.d.).
Abbreviations: VLDL, very low density lipoproteins; LDL, low density
lipoproteins; HDL, high density lipoproteins.
Dietary fat type and lathosterol levels
C Cox
et al
Laboratory methods
Subjects fasted overnight and at approximately midday the
following day (Sunday) venous blood was taken into tubes
containing EDTA. Plasma was separated by low speed
centrifugation of blood at 4
C. VLDL was separated by
ultracentrifugation of plasma according to the Lipid
Research Clinics' protocol (Lipid Research Clinics' Pro-
gram, 1974). HDL cholesterol was measured in the super-
natant after precipitation of apoB-containing lipoproteins
with phosphotungstate and magnesium ions (Assman et al,
1983). Cholesterol (coef®cient of variation 1.6%) and
triglycerides were measured in plasma and plasma frac-
tions using commercial enzymatic kits (Boehringer Man-
nheim, Germany). Plasma apoA±I, and B were measured
by immunoturbidimetry using commercial kits (Boehrin-
ger Mannheim, Germany) and apoA±II was measured by a
modi®cation of a published method (Siedel et al, 1988).
Plasma lathosterol levels were measured by gas±liquid
chromatography as described previously (Sutherland et
al, 1991) and values were also expressed as mmol/mmol
plasma cholesterol to correct for varying numbers of
lipoprotein acceptor particles for the sterol in plasma.
The coef®cient of variation for the lathosterol measure-
ment was typically 4%. Plasma samples for lathosterol
measurement were stored at 780
C until the end of the
study and all samples from an individual were measured
on the same day. Plasma triglyceride fatty acid composi-
tion was also measured by gas±liquid chromatography
(Cox et al, 1995).
Statistical analysis
Analyses were carried out on values from the four week
points in the diet periods. Data from the three diet periods
were compared by ANOVA and when a signi®cant effect
of diet was detected paired t-tests were used to compare
values between pairs of diets. Two-tailed tests of signi®-
cance were used and a P value of less than 0.05 was
considered to be statistically signi®cant.
Forty-one subjects completed the study and four subjects
did not have plasma lathosterol levels measured for tech-
nical reasons and their data were excluded from the present
report. Body weight (mean s.d.) did not change signi®-
cantly during the study (baseline: 91.7 15.2 kg; 4-week
values: butter: 92.5 16.1 kg; coconut: 92.6 16.4 kg, saf-
¯ower: 92.2 16.2 kg).
Table 2 shows plasma lathosterol/cholesterol ratio in
subjects during the dietary intervention periods. In the total
study group, the ratio was signi®cantly different among the
diet periods and was signi®cantly lower during diets rich in
coconut fat and saf¯ower oil compared with diets rich in
butter. Similarly, mean ( s.d.) plasma lathosterol concen-
tration was signi®cantly (P 0.0006, repeated measures
ANOVA) different among the diet periods (butter:
6.86 2.72 mmol/l; coconut: 5.83 1.86 mmol/l; saf¯ower
oil: 5.62 2.38 mmol/l).
Plasma levels of LDL cholesterol and apoB were sig-
ni®cantly lower and plasma triglyceride concentration was
lower at a marginal level of signi®cance at four weeks
during the coconut diet compared with the butter diet.
Plasma cholesterol, LDL cholesterol, HDL cholesterol,
apoA±I and apoB were signi®cantly lower during the saf-
¯ower diet compared with both the butter diet and the
coconut diet. These results are summarised in Table 3.
Plasma cholesterol and triglycerides levels did not change
signi®cantly between weeks four and six in the study. The
pattern of plasma lipid, lipoprotein and apolipoprotein
levels was similar in men and women during the diets.
Age was not correlated signi®cantly with plasma choles-
terol (r 0.231) and log ratio plasma lathosterol/choles-
terol (r 0.173) at baseline and during the study.
Plasma triglyceride lauric acid content was signi®cantly
(P < 0.05) higher during the coconut diet and the content of
linoleic acid was signi®cantly higher during the saf¯ower
diet compared with other diets. Plasma triglyceride content
of myristic acid and palmitic acid were not signi®cantly
different between the diet periods. These results are sum-
marised in Table 4.
In an earlier randomised study in moderately hypercholes-
terolemic subjects we reported that plasma cholesterol and
LDL cholesterol levels were lower during diets rich in
coconut fat and were lower still during diets rich in saf-
¯ower oil compared with diets rich in butter (Cox et al,
1995). The present data con®rm these ®ndings for plasma
LDL cholesterol in healthy subjects. Plasma cholesterol
levels were not clearly lower in spite of reduced LDL
cholesterol levels because levels of plasma HDL choles-
terol and VLDL cholesterol tended to increase when coco-
nut fat replaced butter in the diet. We also report that
plasma lathosterol and the ratio plasma lathosterol/
Table 2 Plasma lathosterol to cholesterol ratio on subjects during butter,
coconut, and saf¯ower oil diets
All subjects Men Women
n 37 n 21 n 16
Diet mmol/mmol cholesterol
Butter 1.24 (0.24)
1.22 (0.49) 1.27 (0.39)
Coconut 1.09 (0.34)
1.04 (0.39) 1.11 (0.36)
Saf¯ower 1.14 (0.49)
1.11 (0.57) 1.19 (0.41)
0.04 0.08 0.56
Values are mean (s.d.).
Values with different superscripts are signi®cantly different by paired
t-test (P < 0.05).
Repeated measures analysis of variances on log-transformed data.
Table 3 Plasma lipids, lipoproteins and apolipoproteins in the subjects
during butter, coconut and saf¯ower diets
n 37
Butter Coconut Saf¯ower P
TC (mmol/l) 5.61 (0.96)
5.47 (0.91)
5.10 (0.93)
VLDL-C (mmol/l) 0.34 (0.18) 0.41 (0.36) 0.45 (0.45) 0.31
LDL-C (mmol/l) 4.08 (0.89)
3.79 (0.75)
3.50 (0.84)
HDL-C (mmol/l) 1.16 (0.24)
1.21 (0.27)
1.06 (0.21)
TG (mmol/l) 1.86 (0.89) 1.61 (0.93) 1.77 (1.25) 0.18
ApoA±I (g/l) 1.23 (0.18)
1.33 (0.28)
1.15 (0.14)
ApoA±II (g/l) 0.34 (0.08) 0.35 (0.08) 0.35 (0.08) 0.31
ApoB (g/l) 1.00 (0.22)
0.87 (0.38)
0.76 (0.18)
Values are mean (s.d.).
Abbreviations: TC, total cholesterol; VLDL-C, very low density
lipoprotein cholesterol; LDL-C, low density lipoprotein; HDL-C, high
density lipoprotein; TG, triglycerides; Apo, apolipoprotein.
Values in the same row with different superscripts are signi®cantly
different by paired t-test (P < 0.01).
Dietary fat type and lathosterol levels
C Cox
et al
cholesterol were lower which may indicate lower choles-
terol synthesis during diets in coconut fat and saf¯ower oil
compared with diets rich in butter.
Since this study was conducted in free-living individuals
reduced compliance with experimental diet regimen could
have potentially in¯uenced results. Participants were given
detailed dietary advice and supplies of the test fats and
special breads baked using these fats. Furthermore, they
were contacted frequently to reinforce dietary instructions.
Plasma triglyceride fatty acid composition which showed
highest levels of lauric acid during the coconut diet, highest
levels of linoleic acid during the saf¯ower oil diet and a
trend toward highest levels of stearic acid during the butter
diet suggests that on average subjects complied satisfacto-
rily with dietary instructions.
Glatz & Katan (1993) have reported a higher ratio
plasma lathosterol/cholesterol and a higher rate of whole
body cholesterol synthesis in subjects consuming diets rich
in saturated fat compared with polyunsaturated fats. Our
data in the present study and in an earlier study (Cox et al,
1996) are in accord with this ®nding. Also, the magnitude
of the differences in the ratio plasma lathosterol/cholesterol
(0.10 mol/mol) and mean plasma cholesterol concentration
(0.52 mmol/l) between the butter diet and the diet rich in
saf¯ower oil are approximately in proportion to the corre-
sponding differences (ratio plasma lathosterol/cholesterol,
0.21 mol/mol; mean plasma cholesterol, 0.93 mmol/l)
reported between SAFA and PUFA diets (Glatz & Katan,
1993). These ®ndings suggest that the average magnitude
of the decrease in cholesterol synthesis may predict the
average magnitude of the decrease in plasma cholesterol
levels when PUFA replaces SAFA in the diet.
It has been postulated previously that the higher rate of
cholesterol synthesis during diets rich in SAFA may be due
to increased synthesis and secretion of VLDL from the liver
(Glatz & Katan, 1993). Synthesis of VLDL is a major drain
on the hepatic cholesterol pool (Shepherd & Packard, 1988)
and apparently activates cholesterol synthesis to maintain a
suf®cient supply of the sterol for lipoprotein synthesis (Goh
& Heimberg, 1979). A close correlation between choles-
terol synthesis rates and VLDL-apoB secretion in normo-
lipidaemic subjects (Watts et al, 1995) is in line with a link
between VLDL production and cholesterol synthesis.
In the present study, the lower ratio plasma lathosterol/
cholesterol suggests that cholesterol synthesis is reduced
during diets rich in coconut fat compared with those rich in
butter. The mechanism underlying a lower rate of choles-
terol synthesis in response to dietary coconut fat is unre-
solved by our data. Conceivably, synthesis and secretion of
VLDL may be decreased which could lead to reduced
requirement for hepatic cholesterol and in turn decreased
cholesterol synthesis. In rhesus monkeys, the production
rate of VLDL-apoB was 3-fold lower in animals fed a diet
rich in coconut fat compared with those fed a diet rich in
palmitic acid in the form of palm oil ((Khosla & Hayes,
1991). However, the effect of a diet rich in coconut fat on
VLDL secretion in humans has not been reported.
On the other hand, it is possible that a lower rate of
cholesterol synthesis during diets rich in coconut fat may
reduce hepatic secretion of VLDL-apoB rather than the
reverse. There is evidence that cholesterol synthesis may be
an important determinant of VLDL-apoB production. The
correlation between cholesterol synthesis and VLDL-apoB
secretion reported previously may indicate that cholesterol
synthesis is a determinant of VLDL production (Watts et
al, 1995). Also, Arad and coworkers (1992) have reported
that inhibition of HMG CoA reductase activity, the rate-
limiting step in cholesterol biosynthesis, by lovastatin
treatment appears to reduce the assembly and secretion of
VLDL in subjects with hyperlipidemia. Lastly, rates of
cholesteryl ester synthesis and apoB secretion are closely
coupled in cultured HepG2 cells incubated with fatty acids
(Cian¯one et al, 1990).
It is unlikely that lathosterol in the diet in¯uenced
appreciably the differences in plasma lathosterol and the
ratio lathosterol/cholesterol during this study. Eggs, which
appear to be the main source of lathosterol in the diet
(Duane, 1995), were added to the diets rich in coconut fat
and saf¯ower oil during which plasma lathosterol levels
and the ratio lathosterol/cholesterol were lower compared
with the butter diets. Furthermore, cholesterol (egg) intake
was maintained low and in a range which probably has
little in¯uence on plasma lathosterol levels.
Since LDL is derived from the intravascular hydrolysis of
VLDL, any decrease in VLDL±apoB secretion could, in
theory, contribute to the lower plasma LDL cholesterol
levels during diets rich in cocount fat compared with diets
rich in butter. However, Watts and coworkers have reported
that plasma LDL cholesterol concentration and VLDL±apoB
secretion rates in normolipidemic men are not correlated
(Watts et al, 1995) which suggests that VLDL±apoB secre-
tion rate may not be a major determinant of plasma LDL
cholesterol levels in man. An increase in LDL receptor
number is probably an important mechanism by which
reduction of dietary saturated fat reduces plasma LDL
cholesterol levels (Mustad et al, 1997). While hepatic LDL
receptor activity (and plasma cholesterol levels) is similar in
hamsters fed diets rich in lauric acid or palmitic acid
(Woollett et al, 1992), the effect of substituting butter with
coconut fat in the diet on LDL receptor numbers in man has
not been determined. Reduced intake of SAFA may lead to
higher numbers of LDL receptors (Mustad et al, 1997) which
may contribute substantially to lower plasma cholesterol and
LDL cholesterol levels during diets rich in saf¯ower oil
compared with those rich in coconut fat (and butter) in the
present study. However, the ratio plasma lathosterol/choles-
terol was similar during these diets which suggests that the
decrease in plasma cholesterol levels when dietary saf¯ower
oil replaced coconut fat is not linked to cholesterol synthesis
or associated metabolic pathways.
Table 4 Plasma triglyceride fatty acid composition in subjects during
butter, coconut and saf¯ower diets
Fatty acid Butter Coconut Saf¯ower
(mol%) (n 18) (n 18) (n 18)
C12:0 0.29 (0.36)
0.80 (0.47)
0.51 (0.31)
C14:0 3.18 (1.12) 2.95 (0.78) 2.74 (0.85)
C14:1 0.21 (0.18) 0.52 (0.87) 0.32 (0.37)
C16:0 29.95 (2.89) 29.20 (2.87) 29.90 (3.26)
C16:1 4.77 (0.87) 5.35 (0.85)
4.44 (0.92)
C18:0 6.34 (1.40) 5.30 (1.32) 5.67 (2.47)
C18:1 n-9 42.21 (4.34)
42.60 (2.98)
38.90 (5.02)
C18:2 n-6 7.46 (3.14)
6.44 (1.89)
10.42 (4.60)
C18:3 n-6 0.11 (0.10)
0.15 (0.09)
0.17 (0.08)
C18:3 n-3 0.08 (0.14)
0.12 (0.18)
0.34 (0.19)
C20:4 n-6 0.18 (0.09)
0.23 (0.14)
0.43 (0.14)
C22:6 n-3 0.27 (0.42) 0.15 (0.23) 0.34 (0.30)
Values are mean (s.d.).
Values in the same row with different superscripts are signi®cantly
different by paired t-test (P < 0.05).
Dietary fat type and lathosterol levels
C Cox
et al
There are limitations to the present ®ndings. Subjects
were not randomized into diet groups and a sequential
study design was used. Therefore, it could be argued that
order of the diets and changes with time including regres-
sion to the mean could affect the results. However, it is
unlikely that these factors were in¯uential because similar
changes in plasma lipids, lipoproteins and apolipoproteins
were recorded in our previous study in subjects who
consumed diets rich in coconut fat, butter and saf¯ower
oil in a randomised cross-over design (Cox et al, 1995). In
the present study, the switch from diets rich in butter to
coconut fat diets (the main comparison) without a washout
period would tend to minimize the effects of this change in
dietary fat on measured variables.
Our data suggest that cholesterol synthesis is reduced
leading to lower plasma lathosterol levels when butter is
replaced by coconut fat in the diet. The mechanism under-
lying this change and its relationship to changes in lipo-
protein metabolism when the composition of dietary fat is
altered remains to be determined.
AcknowledgementsÐThe authors greatly appreciate the cooperation of
participants in the study and the excellent technical and research assistance
of Ashley Duncan, Dean Hackett, Barbara McSkimming, and Margaret
Arad Y, Ramakrishnan R & Ginsberg HN (1992): Effects of lovastatin
therapy on very-low density lipoprotein triglyceride metabolism in
subjects with combined hyperlipidemia: Evidence for reduced assembly
and secretion of triglyceride-rich lipoproteins. Metabolism 41, 487±493.
Assman G, Schriewer H, Schmidt G & Hagele E (1983): Quanti®cation of
high density lipoprotein cholesterol by precipitation with phosphotungs-
tic acid/MgCl
. Clin. Chem. 29, 2026±2030.
rkhem I, Miettinen T, Reihner E, Ewerth S, Angelin B & Einarsson K
(1987): Correlation between serum levels of some cholesterol precur-
sors and activity of HMG CoA reductase in human liver. J. Lipid Res.
28, 1137±1143.
Cian¯one KM, Yasruel Z, Rodriguez MA, Vas D & Sniderman AD
(1990): Regulation of apoB secretion from HepG2 cells: Evidence for
a critical role of cholesterol ester synthesis in the response to a fatty acid
challenge. J. Lipid Res. 31, 2045±2055.
Cortese C, Levy Y, Janus ED, Turner PR, Rao SN, Miller NE & Lewis B
(1983): Modes of action of lipid-lowering diets in man: studies of
apolipoprotein B kinetics in relation to fat consumption and dietary fat
composition. Eur. J. Clin. Invest. 13, 79±85.
Cox C, Mann J, Sutherland W, Chisholm A & Skeaff M (1995): Effects of
coconut oil, butter and saf¯ower oil on lipids and lipoproteins in persons
with moderately elevated cholesterol levels. J. Lipid Res. 36,
Cox CMA, Sutherland WHF, Ball MJ & Mann JI (1996): Response of
plasma lathosterol concentration to change in the quality of dietary fat
in men and women. Eur. J. Clin. Nutr. 50, 358±363.
Denke MA & Grundy SM (1992): Comparison of effects of lauric acid and
palmitic acid on plasma lipids and lipoproteins. Am. J. Clin. Nutr. 56,
Duane WC (1995): Serum lathosterol levels in human subjects re¯ect
changes in whole-body cholesterol synthesis induced by lovastatin but
not dietary cholesterol. J. Lipid Res 36, 343±348.
Glatz JFC & Katan MB (1993): Dietary saturated fatty acids increase
cholesterol synthesis and fecal steroid excretion in healthy men and
women. Eur. J. Clin. Invest. 23, 648±655.
Goh EH & Heimberg M (1979): Relationship between the activity of 3-
hydroxy-3-methylglutaryl Coenzyme A reductase and secretion of very
low density lipoprotein cholesterol in isolated perfused liver and in the
mutant rat. Biochem J 184, 1±6.
Grundy SM & Ahrens EH Jr (1970): The effects of unsaturated dietary fats
on absorption, excretion, synthesis and distribution of cholesterol in
man. J. Clin. Invest. 49, 1135±1152.
Jones PJH, Lichtenstein AH, Schaefer EJ & Namchuk GL (1994): Effect
of dietary fat selection on plasma cholesterol synthesis in older,
moderately hypercholesterolemic humans. Arterioscler. Thromb. 14,
Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA &
Katan MB (1988): Serum lathosterol concentration is an indicator of
whole-body cholesterol synthesis in humans. J. Lipid Res. 29,
Khosla P & Hayes KC (1991): Dietary fat saturation in rhesus
monkeys affect LDL concentrations by modulating the independent
production of LDL apolipoprotein B. Biochim. Biophys. Acta 1083,
Lipid Research Clinics' Program (1974): Manual of Laboratory Opera-
tions. Lipids and Lipoproteins Analysis. DHEW Publication No. (NIH)
75±628, Bethesda, MD, pp. 51±56.
Miettinen TA (1985): Cholesterol precursors and their diurnal rhythm in
populations of patients with jejuno-ileal bypass and ileal dysfunction.
Metabolism 34, 425±430.
Mustad VA, Etherton TD, Cooper AD, Mastro AM, Pearson TA,
Jonnalagadda SS & Kris-Etherton PM (1997): Reducing saturated
fat intake is associated with increased levels of LDL receptors on
mononuclear cells in healthy men and women. J. Lipid Res. 38,
Nestel PJ, Homma Y, Scott TW, Cook LJ & Havenstein N (1976): Effect
of dietary unsaturated pork on plasma lipid and sterol excretion in man.
Lipids 11, 42±48.
Shepherd J, Packard CJ, Grundy SM, Yeshurun D, Gotto, AM & Taunton
OD (1980): Effects of saturated and polyunsaturated fat diets on the
chemical composition and metabolism of low density lipoproteins in
man. J. Lipid Res. 21, 91±99.
Shepherd J & Packard J (1988): Pharmacological control of plasma
cholesterol: Mechanisms of action of hypocholesterolaemic agents. In
Atherosclerosis Reviews, eds. J. Stokes III & M Mancini, p. 109. New
York: Raven Press.
Siedel J, Schlefer S, Rosseneu M, Bergeaud R, De Keersgieter W, Pautz B,
Vinaimont N & Ziegenhorn J (1988): Immunoturbidimetric method for
routine determinations of apolipoproteins A±I, A±II, and B in normo-
and hyperlipidemic sera compared with immunonephelometry. Clin.
Chem. 34, 1821±1825.
Spritz M, Ahrens EH Jr & Grundy SM (1965): Sterol balance in man as
plasma cholesterol concentrations in man are altered by exchange of
dietary fat. J. Clin. Invest. 44, 1482±1493.
Stanhope JM, Sampson VM & Prior AM (1981): The Tokelau island
migrant study: serum lipid concentrations in two environments.
J. Chronic. Dis. 34, 45±55.
Sutherland WHF, Robertson MC, Williamson SA & Nye ER (1991):
Plasma noncholesterol sterols in male distance runners and sedentary
men. Eur. J. Appl. Physiol. 63, 119±123.
Watts GF, Naoumova R, Cummings MH, Umpleby AM, Slavin BM,
nksen PH & Thompson GR (1995): Direct correlation between
cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in
normolipidemic subjects. Metabolism 44, 1052±1057.
Woollett LA, Spady DK & Dietschy JM (1992): Regulatory effects of the
saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein
receptor activity in the hamster. J. Clin. Invest. 89,
Zock PL, de Vries HM & Katan MB (1994): Impact of myristic acid versus
palmitic acid on serum lipid and lipoproteins in healthy men and
women. Arterioscler. Thromb. 14, 567±575.
Dietary fat type and lathosterol levels
C Cox
et al
... According to that study, the levels of TC, LDL-C, HDL-C and triglycerides were found to increase with increasing CNO consumption. In another study, Cox et al. 61 compared the effect of CNO, safflower, and butter consumption on the blood lipid levels of healthy and moderately hypercholesterolemic individuals. 62 The test was designed in a way to derive at least 50% of the total fat energy from the test fat. ...
... Several studies have reported the favorable effect of coconut fats on cardiovascular markers over animal fats. 51,[60][61][62] The SFA profiles of CNO vastly differ from those of animal fats, where CNO is predominantly made of lauric acid (ca 45-53%), while the major FAs of butter are palmitic and stearic acids. 14,51 Studies done on lauric acid metabolism indicate that unlike other saturated fats, lauric acid is rapidly absorbed, directly transported to the liver and oxidized to produce energy rather than being stored as fat. ...
Full-text available
Coconut oil is an integral part of Sri Lankan and many South Asian diets. Initially, coconut oil was classified along with saturated fatty acid food items and criticized for its negative impact on health. However, research studies have shown that coconut oil is a rich source of medium-chain fatty acids. Thus, this has opened new prospects for its use in many fields. Beyond its usage in cooking, coconut oil has attracted attention due to its hypocholesterolemic, anticancer, antihepatosteatotic, antidiabetic, anti-oxidant, anti-inflammatory, antimicrobial and skin moisturizing properties. Despite all the health benefits, consumption of coconut oil is still underrated due to a lack of supportive scientific evidence. Even though studies done in Asian countries claim a favorable impact on cardiac health and serum lipid profile, the limitations in the number of studies conducted among Western countries impede the endorsement of the real value of coconut oil. Hence, long-term extensive studies with proper methodol-ogies are suggested to clear all the controversies and misconceptions of coconut oil consumption. This review discusses the composition and functional properties of coconut oils extracted using various processing methods.
... This trial reiterated that a favorable reduction in LDL-C could be achieved by either reduction of saturated fat (coconut fat) or by partial replacement with UFA. Cox et al. conducted two interventional trials in New Zealand in the 1990s comparing coconut oil with butter and safflower oil [47,48]. The first trial was a randomized crossover trial with 28 adult participants with moderate hypercholesterolemia [47]. ...
... The first trial was a randomized crossover trial with 28 adult participants with moderate hypercholesterolemia [47]. The second trial was a sequential nonrandomized feeding trial involving 41 healthy volunteers of Pacific Island ethnicity [48]. The test fats provided at least 50% of the total fat energy source. ...
... The dose of coconut oil was stated as volume in eight studies [39,40,42,43,52e55] (7e93 mL/day), while in fifteen other studies it was stated as percentage of daily energy (9.3e38%) [33e38, 41,44e51]. A variety of coconut oils has been used, including refined, bleached and deodorized (RBD) coconut oil [35,47,49,51], virgin coconut oil [39,53], hydrogenated coconut oil or undefined [33,34,36e38,40e46,48,50,52,54,55]. Most studies had only one comparison group (n ¼ 12). ...
... In comparison to other oils, coconut oil had no significant effects on TG (4.25 mg/dL; 95% CI, À0.49-8.99, p ¼ 0.08; I 2 ¼ 1%, p ¼ 0.45) (Fig. 5 increased Apo A1 (5 interventions, n ¼ 202) [35,38,40] ...
Full-text available
Background and aims High total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) could be major risk factors for cardiovascular disease burden among high risk populations especially in South Asians. This systematic review and meta-analysis aimed to quantify the effects of coconut oil compared with other oils and fats on cardio-metabolic parameters. Methods PubMed, Scopus and Web of Science were systematically searched. The main outcomes included are lipid and glycemic parameters. Subgroup analyses were performed to evaluate individual comparisons of vegetable oils and animal fat with coconut oil. Data were pooled using random-effects meta-analysis. Results Coconut oil consumption significantly increased TC by 15.42 mg/dL (95% CI, 8.96–21.88, p < 0.001), LDL-C by 10.14 mg/dL (95% CI, 4.44–15.84, p < 0.001) and high density lipoprorein cholesterol (HDL-C) by 2.61 mg/dL (95% CI, 0.95–4.26, p = 0.002), and significantly decreased glycosylated hemoglobin (HbA1c) by 0.39 mg/dL (95% CI, −0.50 to −0.27, p < 0.001) but, it had no effects on triglycerides (TG), (4.25 mg/dL; 95% CI, −0.49-8.99, p = 0.08) when compared with the control group. Sub-group analysis demonstrated that coconut oil significantly increased TC and LDL-C over corn, palm, soybean and safflower oils and not over olive oil. Compared with butter, coconut oil showed a better pattern in cardio-metabolic markers by significantly increasing HDL-C (4.38 mg/dL, 95% CI, 0.40 to 8.36, p = 0.03) and decreasing LDL-C (−14.90 mg/dL, 95% CI, −23.02 to-6.77, p < 0.001). Conclusions Our results suggest that coconut oil consumption results in significantly higher TC, LDL-C and HDL-C than other oils. Consumption of coconut oil can be one of the risk factors for CVDs in South Asians.
... 10 Poleg tega je intervencijska dieta vključevala uživanje kokosovega olja z dodatnim vnosom sadja, ki ima dokazan učinek na izgubljanje teže (Sharma, Chung, Kim in Hong, 2016). 11 Povišan HDL holesterol sam po sebi ni povezan z nižjim tveganjem za srčno-žilne bolezni. Nekateri dedni dejavniki, ki vplivajo na višji HDL holesterol (Voight idr., 2012) ali uživanje zdravil za povišanje HDL holesterola (Barter idr., 2007), niso povezani z manjšim tveganjem za srčnožilne bolezni. ...
Full-text available
Nowadays, we are bombarded on every step with numerous superfoods by salespeople, the media, magazines and social media, which attach them almost magical-like qualities for the human health. In Slovenia, one of such foods is currently also coconut oil, which is regarded by many as a superfood, while its regular consumption is associated with the prevention against numerous modern chronic diseases. Coconut oil is also associated with weight loss and an antimicrobial, anti-inflammatory and antiviral effect. The market offers various food preparations from coconut as a natural plant food, such as coconut flour, beverages, but�ter and virgin or refined oil. Numerous athletes, recreationists and enthusiasts of a healthy and active lifestyle use coconut oil as a part of a healthy diet. Due to non-transparent contradictory information on whether coconut oil is a healthy, “magical” or unhealthy food, the authors will present a relative scientific overview on studies of the influence of consuming coconut oil on the human health, especially in relation to cardiovascular health and the loss of excess weight. By doing so, we wish to increase the readers’ ability to make an informed choice about their eating behavior.
... Os poli-insaturados compreendem em torno de 3 a 5% dos ácidos graxos presentes no cacau. 238 245 o óleo de coco aumenta as concentrações plasmáticas de colesterol total e LDL-c. Estudo em indivíduos normolipidêmicos habitantes do Sri Lanka evidenciou que a substituição isocalórica do óleo de coco por óleo de soja reduziu as concentrações plasmáticas de colesterol total, LDL-c e triglicerídeos. ...
... Safflower oil rich in oleic acid contains less saturated fat and its linoleic acid content is higher than olive oil and may be effective in preventing coronary artery disease [2]. Monounsaturated fatty acids particularly oleic acid can be effective in lowering LDL (Low-Density Lipoprotein) plasma levels without affecting HDL (High-Density Lipoprotein) levels [4]. Despite these various benefits and applications of safflower, it is believed that the production of safflower throughout the world is not sufficient. ...
... Similar results have been observed in previous reports, in which the administration of 1600 mg kg − 1 of GML led to a significant reduction in the serum LDL-C level in mice (Mo et al., 2019). Likewise, several studies reported that dietary coconut oil as a MCFA source resulted in lowering of serum LDL-C level in broiler and human (Cox et al., 1998(Cox et al., , 1994Wang et al., 2015). The histological hepatic lipid deposition analysis by oil red O staining showed lipid droplets were evenly dispersed and no fat accumulation could be observed in the GML group. ...
Full-text available
Microbial recurrent infections and antimicrobial resistance have motivated the researchers to explore bioactive compounds as safe alternative antimicrobials to target pathogenic microorganisms. Interest in finding new biologically active substances to replace conventional antibiotics in aquatic feed has rapidly increased, since the misuse or overuse of antibiotics produced antibiotic resistance. Glycerol monolaurate (GML), has attracted attention of researchers due to its growth-promoting and immunomodulatory potential by exerting beneficial effects on the gut microbiota and host health. This study aimed to evaluate the effects of dietary GML using as a feed additive on the growth performance, blood lipid profile, hepatic lipid deposition, body composition, digestive enzymes, serum anti-inflammatory activities, and gut microbiota of zebrafish. The study’s findings showed that diet supplemented with 750 mg kg⁻¹ of GML, significantly improved the growth performance, feed utilization and intestinal lipase activity, as well as body crude lipid content without inducing hepatic fat accumulation. GML supplementation also promoted the serum anti-inflammatory potential by elevating the level of TGF-β1 and IL-10. Moreover, dietary supplementation of GML positively restructured the intestinal microbial ecology by improving the relative abundance of several favorable bacteria, including Cetobacterium, Shewanella, and Vibrio at the genus level. Conclusively, study’s findings suggest that GML supplementation contributes in improving the growth, digestive enzymes activities, anti-inflammatory potential, and gut microbiota, indicating GML promising potential as a feed additive in aquaculture nutrition.
... 369 Coconut oil is able to increase plasma concentrations of TC and LDLc compared to other fats such as olive oil 370 and safflower oil. 371 A study in humans showed that lauric acid elevates TC and LDLc, compared to a MUFA-rich diet, but less markedly than palmitic acid. 372,373 Mendis et al. 373 found that the isocaloric replacement of coconut oil, typically found in the diet of Sri Lankan people, with soybean oil rich in PUFAs reduced the plasma concentrations of TC, LDLc, and TG in normolipidemic individuals. ...
Full-text available
Understanding the complex pathogenesis of COVID-19 continues to evolve. With observation and quarantine as the prevailing standard of care, this study evaluated the effects of virgin coconut oil (VCO) in the biochemical markers of suspect and probable cases of COVID-19. A 28-day randomized, double-blind, controlled intervention was conducted among 63 adults in two isolation facilities in Santa Rosa City, Laguna, Philippines. The participants were randomly assigned to receive either a standardized meal (control) or a standardized meal mixed with a predefined dosage of VCO. Changes in clinical markers were measured at three time points (day 0, 14, and 28), with daily monitoring of COVID-19 symptoms. Participants in the intervention group showed a significant decline in the C-reactive protein level, with the mean CRP level normalized to ≤5 mg/dL on the 14th day of the intervention. As an adjunct therapy, meals mixed with VCO is effective fostering faster recovery from COVID-19.
Background and Aims There is some promising evidence regarding the beneficial effect of coconut oil on cardiometabolic risk factors. This study aimed to assess the effects of virgin coconut oil (VCO) consumption on metabolic syndrome (MetS) components, as well as, asymmetric dimethylarginine (ADMA) in adults with MetS. Methods and Results In this randomized controlled trial, 48 subjects, aged 20–50 years, with MetS were allocated into two groups; the intervention group was given 30 ml of VCO per day to substitute the same amounts of fat in their usual diet for four weeks. The control group was advised to follow their usual diet. VCO consumption significantly reduced serum levels of triglyceride (TG) (P=0.001), very low-density lipoprotein (VLDL) (P=0.001), and fasting blood sugar (FBS) (P=0.015) compared to the control group. The levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) were significantly increased in the VCO group when compared to the control group (P=0.001). Circulatory ADMA also increased in the VCO group compared to the control group (P=0.003). No significant differences were observed in the LDL-C/HDL-C ratio, anthropometric parameters, and blood pressure measurements between the two groups at the end of the study (P>0.05). Conclusion VCO consumption increased the values of HDL-C while reduced TG and FBS levels. Blood pressure and waist circumference did not change. However, levels of TC, LDL-C, and ADMA elevated by VCO consumption. Caution is warranted until the results of further studies become available to explain the long-term effects of VCO consumption. Registration number IRCT20131125015536N11
Full-text available
The hepatic output of triacylglycerol and cholesterol from very-low-density lipoprotein (VLD lipoprotein), and the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase were compared in the isolated perfused rat-liver preparation and in the intact rat. The output of triacylglycerol and cholesterol from VLD lipoprotein by the perfused liver was stimulated by oleate concomitant with stimulation of hepatic microsomal hydroxymethylglutaryl-coenzyme A reductase activity. In the intact animal treated with Triton WR-1339, the magnitude of secretion of triacylglycerol and cholesterol from VLD lipoprotein coincided with the diurnal rhythm of hepatic hydroxymethylglutaryl-coenzyme A reductase activity, which was maximal at 24:00 h and minimal at 12:00 h. These observations suggest that the stimulation of the reductase and of the secretion of cholesterol from VLD lipoprotein by non-esterified fatty acids, as observed with the isolated perfused rat liver preparation in vitro, may also be an important physiological mechanism in vivo. Hepatic cholesterogenesis may be stimulated under conditions conductive to the secretion of the VLD lipoprotein, the primary transport form for triacylglycerol in the postabsorptive state.
We evaluated the use of a modified phosphotungstic acid/MgCl2 precipitation procedure for the precipitation of apolipoprotein B-containing lipoproteins. Precipitation of these lipoproteins [very-low- and low-density lipoproteins, and lipoprotein (a)] is complete, with negligible coprecipitation of high-density lipoprotein subfractions (HDL1, HDL2, HDL3), even in hypertriglyceridemic sera. In comparison with ultracentrifugation, the precipitation method yields, on the average, values that are 0.17 mmol/L lower for cholesterol values but almost identical for apolipoprotein A-I and phosphatidylcholine. Looking for delta 3,5-cholestadiene formed from cholesterol in the precipitation residue, we used "high-performance" liquid chromatography and "high-performance" thin-layer chromatography and found none.
In 1987, using quality as a focal point, an extensive effort was undertaken to research, develop, implement, document, and periodically revise all methods used in SMCAR- CCB-RT's Chemistry Laboratory operations. The resulting information is compiled in this manual and should provide a useful starting point for responsible and efficient operations in the future.
Cholesterol synthesis and its diurnal variation was studied by measuring squalene, free and esterified methyl sterols and cholesterol, and triglycerides in serum lipoproteins every four hours over a period of 24 hours in controls and in patients with jejunoileal bypass or ileal exclusion. Fat absorption, as indicated by postprandial increase of very-low-density lipoprotein (VLDL) lipids (including chylomicrons) and fecal fat, was markedly impaired in jejunoileal bypass. Fecal analysis indicated that bile acid malabsorption enhanced cholesterol synthesis about sixfold in ileal dysfunction, and twofold in jejunoileal bypass with moderate bile acid and cholesterol malabsorption. The squalene contents were not increased consistently in the VLDL and combined low-density plus high-density lipoproteins (LDL + HDL) of the two operated groups and, in contrast to the controls, the diurnal variation was inconsistent. The levels of unesterified methyl sterols, delta 8-dimethylsterol and delta 8-methostenol in particular, were several times higher throughout the 24 hour period in the lipoproteins of the two patient groups than of the controls, were higher in ileal dysfunction than jejunoileal bypass, exhibited a constant diurnal rhythm in the controls but only in the relatively small VLDL fraction (not in the large LDL + HDL) of the operated groups, and were positively correlated with cholesterol synthesis in the three groups combined (for methyl sterols in VLDL r = 0.740 and in LDL + HDL r = 0.869). Esterified methyl sterols were also increased in the operated groups but were not correlated with cholesterol synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)
Pork, enriched in linoleic acid content, was compared iwth conventional pork in the diet of three human subjects with respect to the plasma cholesterol concentration and the excretion in feces of neutral sterols and bile acids. Since the fatty acids in pork glyceride have an unusual positional distribution, the redistribution that might occur during the absorption and disposition of a fat meal was also studied. The plasma cholesterol was lower with polyunsaturated pork, the difference, 14 mg/100 ml plasma, being of the order expected from the change in polyunsaturated to saturated fatty acid ratio. On average, the excretion of neutral sterols was 57% greater with polyunsaturated than with conventional pork in all three subjects, and in this respect the results resembled the findings with polyunsaturated ruminant fats. During the absorption of pork fat, the high proportion of palmitate in the 2 position of lard triglyceride served as a useful marker, since human triglyceride carries mainly unsaturated fatty acids in that position. There were stepwise changes in the fatty acid composition at the 2 position of triglyceride as the fat was absorbed, transported through, and cleared from plasma, the palmitate being gradually replaced by oleate and linoleate. By contrast, the total fatty acid profile in the triglyceride changed relatively little, implying selective reacylation with palmitate at the 1 and/or 3 position. During the clearing of dietary triglyceride, the porcine triglyceride was thus converted to the form occuring in humans.
The effects of lauric acid (C12:0) on plasma lipids and lipoproteins were compared with the effects of palmitic acid (C16:0) and oleic acid (C18:1) in a metabolic-diet study of 14 men by using liquid-formula diets fed for 3 wk each in random order. Lauric acid was supplied in a synthetic high-lauric oil, palmitic acid was provided by palm oil and oleic acid in oleic-rich sunflower seed oil. The high-lauric oil resulted in higher concentrations of plasma total cholesterol (4.94 +/- 0.75 mmol/L [mean +/- SE]) and LDL cholesterol (3.70 +/- 0.57 mmol/L) when compared with high-oleic sunflower oil (4.44 +/- 0.54 and 3.31 +/- 0.44 mmol/L, respectively), but did not raise total and LDL cholesterol concentrations as much as did palm oil (5.17 +/- 0.65 and 3.93 +/- 0.51 mmol/L, respectively). No differences were noted in plasma triglycerides or HDL cholesterol. Lauric acid raises total and LDL cholesterol concentrations compared with oleic acid, but is not as potent for increasing cholesterol concentrations as is palmitic acid.
The plasma concentration of cholesterol carried in low density lipoproteins is principally determined by the level of LDL receptor activity (Jm) and the LDL-cholesterol production rate (Jt) found in animals or man. This study delineates which saturated fatty acids alter Jm and Jt and so increase the plasma LDL-cholesterol level. Jm and Jt were measured in vivo in hamsters fed a constant level of added dietary cholesterol (0.12%) and triacylglycerol (10%), where the triacylglycerol contained only a single saturated fatty acid varying in chain length from 6 to 18 carbon atoms. After feeding for 30 d, the 12:0, 14:0, 16:0, and 18:0 fatty acids, but not the 6:0, 8:0, and 10:0 compounds, became significantly enriched in the liver total lipid fraction of the respective groups fed these fatty acids. However, only the 12:0, 14:0, and 16:0 fatty acids, but not the 6:0, 8:0, 10:0, and 18:0 compounds, suppressed Jm, increased Jt, and essentially doubled plasma LDL-cholesterol concentrations. Neither the 16:0 nor 18:0 compound altered rates of cholesterol synthesis in the extrahepatic organs, and both lowered the hepatic total cholesterol pool. Thus, the different effects of the 16:0 and 18:0 fatty acids could not be attributed to a difference in cholesterol delivery to the liver. Since these changes in LDL kinetics took place without an apparent alteration in external sterol balance, the regulatory effects of the 12:0, 14:0, and 16:0 fatty acids presumably are mediated through some change in a putative intrahepatic regulatory pool of sterol in the liver.
We have previously reported decreased production rates of the major apolipoprotein B (apoB)-containing lipoproteins, very-low-density lipoproteins (VLDL), and low-density lipoproteins (LDL) in patients with combined hyperlipidemia (CHL) during treatment with lovastatin. In the present study, we determined the effects of lovastatin therapy on VLDL triglyceride (TG) metabolism. Plasma VLDL turnover was determined in six CHL patients, before and during lovastatin therapy. 3H-triglyceride-glycerol-specific activity data derived from injection of 3H-glycerol were analyzed by compartmental modeling. The effects of lovastatin on VLDL TG metabolism were compared with those previously determined on VLDL apoB metabolism in these subjects. Lovastatin therapy was associated with decreased concentrations of VLDL TG in five of six patients and decreased VLDL apoB concentrations in all six. VLDL TG production rates (PR) decreased in five patients, with the mean for the group decreasing from 14.1 +/- 7.1 to 10.3 +/- 4.0 mg/kg/h (P less than .05). VLDL apoB PR also decreased in five patients, with the mean decreasing from 21.8 +/- 20.3 to 12.2 +/- 9.0 mg/kg/d (P = .11). Changes in VLDL TG concentrations during lovastatin treatment were correlated with changes in VLDL apoB concentrations (r = .74, P = .09) and in VLDL TG PR (r = .91, P = .01). Changes in VLDL TG PR were also related to changes in VLDL apoB PR (r = .62, P = NS). There were no consistent changes in the fractional catabolic rates of either VLDL TG or VLDL apoB during lovastatin therapy.(ABSTRACT TRUNCATED AT 250 WORDS)